|
1
|
Floodeen H, Lindgren R, Hallböök O and
Matthiessen P: Evaluation of long-term anorectal function after low
anterior resection: A 5-year follow-up of a randomized multicenter
trial. Dis Colon Rectum. 57:1162–1168. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hong YS, Nam BH, Kim KP, Kim JE, Park SJ,
Park YS, Park JO, Kim SY, Kim TY, Kim JH, et al: Oxaliplatin,
fluorouracil, and leucovorin versus fluorouracil and leucovorin as
adjuvant chemotherapy for locally advanced rectal cancer after
preoperative chemoradiotherapy (ADORE): An open-label, multicentre,
phase 2, randomised controlled trial. Lancet Oncol. 15:1245–1253.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reima H, Saar H, Innos K and Soplepmann J:
Methylene blue intra-arterial staining of resected colorectal
cancer specimens improves accuracy of nodal staging: A randomized
controlled trial. Eur J Surg Oncol. 42:1642–1646. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu K, Yao H, Lei S, Xiong L, Qi H, Qian
K, Liu J, Wang P and Zhao H: The miR-124-p63 feedback loop
modulates colorectal cancer growth. Oncotarget. 8:29101–29115.
2017.PubMed/NCBI
|
|
5
|
Monzo M, Santasusagna S, Moreno I,
Martinez F, Hernández R, Muñoz C, Castellano JJ, Moreno J and
Navarro A: Exosomal microRNAs isolated from plasma of mesenteric
veins linked to liver metastases in resected patients with colon
cancer. Oncotarget. 8:30859–30869. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu K, Zhao Z, Ma J, Chen J, Peng J, Yang S
and He Y: Deregulation of miR-193b affects the growth of colon
cancer cells via transforming growth factor-β and regulation of the
SMAD3 pathway. Oncol Lett. 13:2557–2562. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nagappan A, Lee WS, Yun JW, Lu JN, Chang
SH, Jeong JH, Kim GS, Jung JM and Hong SC: Tetraarsenic hexoxide
induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt
suppression and p38 MAPK activation in SW620 human colon cancer
cells. PLoS One. 12:e01745912017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang LL, Mu GG, Ding QS, Li YX, Shi YB,
Dai JF and Yu HG: Phosphatase and tensin homolog (PTEN) represses
colon cancer progression through inhibiting paxillin transcription
via PI3K/AKT/NF-κB pathway. J Biol Chem. 290:15018–15029. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao Y, Xiao X, Zhang C, Yu W, Guo W, Zhang
Z, Li Z, Feng X, Hao J, Zhang K, et al: Melatonin synergizes the
chemotherapeutic effect of 5-fluorouracil in colon cancer by
suppressing PI3K/AKT and NF-κB/iNOS signaling pathways. J Pineal
Res. 62:e123802017. View Article : Google Scholar
|
|
10
|
Waligórska-Stachura J, Jankowska A, Waśko
R, Liebert W, Biczysko M, Czarnywojtek A, Baszko-Błaszyk D, Shimek
V and Ruchała M: Survivin - prognostic tumor biomarker in human
neoplasms - review. Ginekol Pol. 83:537–540. 2012.PubMed/NCBI
|
|
11
|
Hwang JS, Lee HC, Oh SC, Lee DH and Kwon
KH: Shogaol overcomes TRAIL resistance in colon cancer cells via
inhibiting of survivin. Tumour Biol. 36:8819–8829. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hsu YF, Sheu JR, Lin CH, Yang DS, Hsiao G,
Ou G, Chiu PT, Huang YH, Kuo WH and Hsu MJ: Trichostatin A and
sirtinol suppressed survivin expression through AMPK and p38MAPK in
HT29 colon cancer cells. Biochim Biophys Acta. 1820:104–115. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim CW, Baek JH, Choi GS, Yu CS, Kang SB,
Park WC, Lee BH, Kim HR, Oh JH, Kim JH, et al: The role of primary
tumor resection in colorectal cancer patients with asymptomatic,
synchronous unresectable metastasis: Study protocol for a
randomized controlled trial. Trials. 17:342016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Augestad KM, Norum J, Rose J and Lindsetmo
RO: A prospective analysis of false positive events in a National
Colon Cancer Surveillance Program. BMC Health Serv Res. 14:1372014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu Y, Chen L, Ko TC, Fields AP and
Thompson EA: Evi1 is a survival factor which conveys resistance to
both TGFbeta- and taxol-mediated cell death via PI3K/AKT. Oncogene.
25:3565–3575. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tabusa H, Brooks T and Massey AJ:
Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS
colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT
signaling. Mol Cancer Res. 11:109–121. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kureel J, Dixit M, Tyagi AM, Mansoori MN,
Srivastava K, Raghuvanshi A, Maurya R, Trivedi R, Goel A and Singh
D: miR-542-3p suppresses osteoblast cell proliferation and
differentiation, targets BMP-7 signaling and inhibits bone
formation. Cell Death Dis. 5:e10502014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li XY and Wang X: The role of human
cervical cancer oncogene in cancer progression. Int J Clin Exp Med.
8:8363–8368. 2015.PubMed/NCBI
|
|
19
|
Jang HJ, Hong EM, Kim M, Kim JH, Jang J,
Park SW, Byun HW, Koh DH, Choi MH, Kae SH, et al: Simvastatin
induces heme oxygenase-1 via NF-E2-related factor 2 (Nrf2)
activation through ERK and PI3K/Akt pathway in colon cancer.
Oncotarget. 7:46219–46229. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Moench R, Grimmig T, Kannen V, Tripathi S,
Faber M, Moll EM, Chandraker A, Lissner R, Germer CT, Waaga-Gasser
AM, et al: Exclusive inhibition of PI3K/Akt/mTOR signaling is not
sufficient to prevent PDGF-mediated effects on glycolysis and
proliferation in colorectal cancer. Oncotarget. 7:68749–68767.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cai J, Zhao J, Zhang N, Xu X, Li R, Yi Y,
Fang L, Zhang L, Li M, Wu J, et al: MicroRNA-542-3p suppresses
tumor cell invasion via targeting AKT pathway in human astrocytoma.
J Biol Chem. 290:24678–24688. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li W, Lee MR, Choi E and Cho MY:
Clinicopathologic significance of survivin expression in relation
to CD133 expression in surgically resected stage II or III
colorectal cancer. J Pathol Transl Med. 51:17–23. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang R, Kang Y, Löhr CV, Fischer KA,
Bradford CS, Johnson G, Dashwood WM, Williams DE, Ho E and Dashwood
RH: Reciprocal regulation of BMF and BIRC5 (Survivin)
linked to Eomes overexpression in colorectal cancer. Cancer Lett.
381:341–348. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao F, Zhang Y, Yang F, Wang P, Wang W, Su
Y and Luo W: survivin promotes the invasion of human colon
carcinoma cells by regulating the expression of MMP-7. Mol Med Rep.
9:825–830. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang H, Li S, Luo X, Song Z, Long X and
Zhu X: Knockdown of PARP6 or survivin promotes cell apoptosis and
inhibits cell invasion of colorectal adenocarcinoma cells. Oncol
Rep. 37:2245–2251. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang J, Wang S, Han F, Li J, Yu L, Zhou
P, Chen Z, Xue S, Dai C and Li Q: MicroRNA-542-3p suppresses
cellular proliferation of bladder cancer cells through
post-transcriptionally regulating survivin. Gene. 579:146–152.
2016. View Article : Google Scholar : PubMed/NCBI
|
